Credit Suisse Ag Tricida, Inc. Transaction History
Credit Suisse Ag
- $101 Billion
- Q1 2024
Shares
15 transactions
Others Institutions Holding TCDA
# of Institutions
4Shares Held
30KCall Options Held
124KPut Options Held
46.5KAbout Tricida, Inc.
- Ticker TCDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,668,900
- Market Cap $557K
- Description
- Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...